Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
As CROs and CDMOs expand their role in biopharma development and manufacturing, fast, accurate bioanalytic technologies remain critical to biotherapeutic affordability ...
Rising Pharmaceutical R&D Spending, Expanding Clinical Diagnostics Demand, and Rapid Advancement in Mass Spectrometry and Multi-Omics Technologies Accelerate Global Proteomics Market Growth.Austin, ...
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small-cell lung cancer will benefit from immunotherapy.
Scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a new way to determine atomic structures from nanocrystals previously considered unusable, ...
Smithsonian researcher Sarah Johnson studies bison specimens to understand how the species’s genetic diversity changed after its decline ...
The gut microbiome research field has rapidly evolved, driven by new insights into the profound ways in which gut microbes affect metabolism, immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results